A hybrid approach with modified RCNN-based ROI identification and spot detect-X fusion strategy for DNA microarray analysis.

As the fourth most frequent type of cancer in both men and women, lymphoid malignancies pose a significant threat to healthcare. This type of cancer has also contributed to increased mortality rates due to the inaccurate detection of diseases. To address the limitations of existing approaches, a novel method called a Hybrid Modified RCNN-based ROI Identification and Spot Detect-X Fusion Strategy for DNA microarray analysis is proposed. Initially, the data undergoes pre-processing using various techniques such as Image Augmentation, Quantile Normalization, Background Correction, and Noise Reduction with an Improved Median Filter. ROI identification is performed using the modified RCNN. Subsequently, features are extracted, and feature selection is based on the Hybrid Anaconda-based Serval Optimization. Finally, diseases are classified using the Spot Detect-X Fusion Strategy. The proposed model achieved an accuracy of 98.98% when implemented in a MATLAB platform. Therefore, the recommended model demonstrates superior performance compared to existing methods. [ABSTRACT FROM AUTHOR]

Copyright of International Journal of Innovative Research & Scientific Studies is the property of International Journal of Innovative Research & Scientific Studies and its content may not be copied or emailed to multiple sites without the copyright holder's express written permission. Additionally, content may not be used with any artificial intelligence tools or machine learning technologies. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.)